(Q50878615)

24 March 2018

review article

1 reference

title

Programmes to reduce pelvic inflammatory disease--the Swedish experience. (English)

1 reference

24 March 2018

pelvic inflammatory diseases

main subject

Sweden

0 references

0 references

inflammation

0 references

author name string

F Kamwendo

1

1 reference

24 March 2018

L Forslin

2

1 reference

24 March 2018

L Bodin

3

1 reference

24 March 2018

D Danielsson

4

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

24 March 2018

published in

The Lancet

1 reference

24 March 2018

volume

351 Suppl 3

1 reference

24 March 2018

page(s)

25-28

1 reference

24 March 2018

Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Analysis of ectopic pregnancy data using marginal and conditional models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Predicting acute pelvic inflammatory disease: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Acute pelvic inflammatory disease in an indigent population. An estimate of its incidence and relationship to methods of contraception.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Economic consequences of pelvic inflammatory disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Trends for gonorrhea and pelvic inflammatory disease in England and Wales and for gonorrhea in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Polymicrobial etiology of acute pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Chilamydia trachomatis infection in patients with acute salpingitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Gonorrhea, genital chlamydial infection, and nonspecific urethritis in male partners of women hospitalized and treated for acute pelvic inflammatory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Preventing pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

Treatment of acute non-tuberculous salpingitis with antibiotics alone and in combination with glucocorticoids:A Prospective double blind controlled study of the clinical course and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990008-3

7 January 2021

10.1016/S0140-6736(98)90008-3

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

9652718

1 reference

24 March 2018